Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J BURKE

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Cancer Research|September 1, 1984
Correlation of proliferative and clonogenic tumor cells in multiple myelomaJ E Karp, P J Burke, P L Saylor, et al.
Cancer Research|June 1, 1981
Diamine oxidase as a plasma marker of rat intestinal mucosal injury and regeneration after administration of 1-beta-D-arabinofuranosylcytosineG D Luk, W P Vaughan, P J Burke, et al.
Archives of Dermatology|January 1, 1991
Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruptionT D Horn, P J Burke, J E Karp, et al.
Cancer Research|November 1, 1984
Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolismJ E Karp, R C Donehower, G B Dole, et al.
Blood Cells|January 1, 1982
Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapyP J Burke, J E Karp, W P Vaughan, et al.
American Journal of Ophthalmology|January 15, 1985
Minimum concentration of levobunolol required to control intraocular pressure in patients with primary open-angle glaucoma or ocular hypertensionD Long, T Zimmerman, G Spaeth, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Tumour localization using monoclonal antibodies. II. Biodistribution of A5B7/111indium chelatesP Barnett, R G Buckley, P J Burke, et al.
Blood|March 1, 1986
Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemiaB A Zehnbauer, D M Pardoll, P J Burke, et al.
Oncology (Williston Park, N.Y.)|July 1, 1990
Management of infectious complications of acute leukemia and antileukemia therapyJ E Karp, W G Merz, J D Dick, et al.
Journal of Medicinal Chemistry|October 14, 1994
Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzymeA B Mauger, P J Burke, H H Somani, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Cancer Research|September 1, 1984
Correlation of proliferative and clonogenic tumor cells in multiple myelomaJ E Karp, P J Burke, P L Saylor, et al.
Cancer Research|June 1, 1981
Diamine oxidase as a plasma marker of rat intestinal mucosal injury and regeneration after administration of 1-beta-D-arabinofuranosylcytosineG D Luk, W P Vaughan, P J Burke, et al.
Archives of Dermatology|January 1, 1991
Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruptionT D Horn, P J Burke, J E Karp, et al.
Cancer Research|November 1, 1984
Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolismJ E Karp, R C Donehower, G B Dole, et al.
Blood Cells|January 1, 1982
Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapyP J Burke, J E Karp, W P Vaughan, et al.
American Journal of Ophthalmology|January 15, 1985
Minimum concentration of levobunolol required to control intraocular pressure in patients with primary open-angle glaucoma or ocular hypertensionD Long, T Zimmerman, G Spaeth, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Tumour localization using monoclonal antibodies. II. Biodistribution of A5B7/111indium chelatesP Barnett, R G Buckley, P J Burke, et al.
Blood|March 1, 1986
Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemiaB A Zehnbauer, D M Pardoll, P J Burke, et al.
Oncology (Williston Park, N.Y.)|July 1, 1990
Management of infectious complications of acute leukemia and antileukemia therapyJ E Karp, W G Merz, J D Dick, et al.
Journal of Medicinal Chemistry|October 14, 1994
Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzymeA B Mauger, P J Burke, H H Somani, et al.
Pageof 12